Nocturnal but not short hours quotidian hemodialysis requires an elevated dialysate calcium concentration

Journal of the American Society of Nephrology

Volumn 14, Issue 9, 2003, Pages 2322-2328

  Al Hejaili, Fayez ^a   Kortas, Claude ^a   Leitch, Rosemary ^a   Heidenheim, A Paul ^a   Clement, Laurie ^a   Nesrallah, Gihad ^a   Lindsay, Robert M ^a,b  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b LONDON HEALTH SCIENCES CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; CALCIUM; PARATHYROID HORMONE; PHOSPHATE; PHOSPHORUS;

ADULT; AGE; ARTICLE; BONE MASS; CALCIUM METABOLISM; CIRCADIAN RHYTHM; CLINICAL ARTICLE; COMORBIDITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIALYSATE LEVEL; DIALYSIS; FEMALE; HEMODIALYSIS; HOME CARE; HUMAN; MALE; PHOSPHATE METABOLISM; PRIORITY JOURNAL; RISK FACTOR; SELF CARE; SEX DIFFERENCE; TREATMENT PLANNING;

EID: 0042320433     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ASN.0000083044.42480.C1     Document Type: Article

References (27)

1. Pierratos A, Ouwendyk M, Francoeur R, Vas S, Raj DS, Ecclestone AM, Langos V, Uldall R: Nocturnal hemodialysis: Three-year experience(Abstract). J Am Soc Nephrol 9: 859-868, 1998
2. Pierratos A: Nocturnal home haemodialysis: An update on a 5-year experience. Nephrol Dial Transplant 14: 2835-2840, 1999
3. Payne RB, Little AJ, Williams RB, Milner JR: Interpretation of serum calcium in patients with abnormal serum proteins. Br Med J 4: 643-6, 1973
4. Naveh-Many T, Rahamimov R, Livni N, Silver J: Parathyroid cell proliferation in normal and chronic renal failure rats. The effects of calcium, phosphate, and vitamin D. J Clin Invest 96: 1786-1793, 1995
5. Argiles A, Mourad G: How do we have to use the calcium in the dialysate to optimize the management of secondary hyperparathyroidism? Nephrol Dial Transplant 13[Suppl 31: 62-64, 1998
6. Bone JM, Davison AM, Robson JS: Role of dialysate calcium concentration in osteoporosis in patients on haemodialysis. Lancet 1: 1047-1049, 1972
7. Bouillon R, Verberckmoes R, Moor PD: Influence of dialysate calcium concentration and vitamin D on serum parathyroid hormone during repetitive dialysis. Kidney Int 7: 422-432, 1975
8. Denney JD, Sherrard DJ, Nelp WB, Chesnut CH 3rd, Baylink DJ: Total body calcium and long-term calcium balance in chronic renal disease. J Lab Clin Med 82: 226-240, 1973
9. Raman A, Chong YK, Sreenevasan GA: Effects of varying dialysate calcium concentrations on the plasma calcium fractions in patients on dialysis. Nephron 16: 181-187, 1976
10. Strong HE, Schatz BC, Shinaberger JH, Coburn JW: Measurement of dialysance and bi-directional fluxes of calcium in vivo using radiocalcium. Trans Am Soc Artif Intern Organs 17: 108-115, 1971
11. Ritz E, Passlick-Deetjen J, Lippert J: What is the appropriate dialysate calcium concentration for the dialysis patient? Nephrol Dial Transplant 11[Suppl 3]: 91-95, 1996
12. Alfrey AC, LeGendre GR, Kaehny WD: The dialysis encephalopathy syndrome. Possible aluminum intoxication. N Engl J Med 294: 184-188, 1976
13. Berlyne GM: Hyperaluminaemia from aluminium resins. Lancet 2: 1253, 1970
14. Slatopolsky E, Weerts C, Lopez-Hilker S, Norwood K, Zink M, Windus D, Delmez J: Calcium carbonate as a phosphate binder in patients with chronic renal failure undergoing dialysis. N Engl J Med 315: 157-161, 1986
15. Meric F, Yap P, Bia MJ: Etiology of hypercalcemia in hemodialysis patients on calcium carbonate therapy. Am J Kidney Dis 16: 459-464, 1990
16. Winchester JF, Rotellar C, Goggins M, Robino D, Rakowski TA, Argy WP: Calcium and phosphate balance in dialysis patients. Kidney Int 41: S174-S178, 1993
17. Felsenfeld AJ, Llach F: Parathyroid gland function in chronic renal failure. Kidney Int 43: 771-789, 1993
18. Fernandez E, Montoliu J: Successful treatment of massive uraemic tumoral calcinosis with daily haemodialysis and very low calcium dialysate. Nephrol Dial Transplant 9: 1207-1209, 1994
19. Fernandez E, Borras M, Pais B, Montoliu J: Low-calcium dialysate stimulates parathormone secretion and its long-term use worsens secondary hyperparathyroidism. J Am Soc Nephrol 6: 132-135, 1995
20. Vos PF, Zilch O, Kooistra MP: Clinical outcome of daily dialysis. Am J Kidney Dis 37[1 Suppl 2]: S99-S102, 2001
21. Woods JD, Port FK, Orzol S, Buoncristiani U, Young E, Wolfe RA, Held PJ: Clinical and biochemical correlates of starting "daily" hemodialysis. Kidney Int 55: 2467-2476, 1999
22. Buoncristiani U, Quintaliani G, Cozzari M, Giombini L, Ragaiolo M: Daily dialysis: Long-term clinical metabolic results. Kidney Int 24: S137-S140, 1988
23. Mucsi I, Hercz G, Uldall R, Ouwendyk M, Francoeur R, Pierratos A: Control of serum phosphate without any phosphate binders in patients treated with nocturnal hemodialysis. Kidney Int 53: 1399-1404, 1998
24. O'Sullivan DA, McCarthy JT, Kumar R, Williams AW: Improved biochemical variables, nutrient intake, and hormonal factors in slow nocturnal hemodialysis: A pilot study. Mayo Clin Proc 73: 1035-1045, 1998
25. McPhatter LL, Lockridge RS Jr, Albert J, Anderson H, Craft V, Jennings FM, Spencer M, Swafford A, Barger T, Coffey L: Nightly home hemodialysis: Improvement in nutrition and quality of life. Adv Ren Replace Ther 6: 358-365, 1999
26. Lindsay RM, Kortas C, Daily/Nocturnal Dialysis Study Group: Hemeral (daily) hemodialysis. Adv Ren Replace Ther 8: 236-249, 2001
27. Lockridge RS: Nightly home hemodialysis (NHHD), future treatment "option of choice": Fifteen months of experience in Lynchburg, Virginia. Home Hemodial Int 3: 23-28, 1999